FDA halts actions on makers of compounded drugs as it reviews decision to remove Eli Lilly's (LLY) weight loss drug ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented ...

The Bank of England risks inflicting unnecessary damage to the economy by keeping interest rates too high for too long, a ...

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the ...

0544 ET – GSK’s $2.2 billion settlement to resolve the majority of Zantac litigation cases was welcomed by the market, with ...

Lawyers representing 10 groups of plaintiffs, or 80,000 liability cases across the US, have backed the payout. There remain another few thousand cases not covered by the payout. GSK will also pay a ...

The FTSE 100 index closed down 6.01 points, 0.1%, at 8,237.73. The FTSE 250 ended 114.01 points lower, 0.6%, at 20,708.37, and the AIM All-Share fell 2.13 points, 0.3%, to 734.53.

GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...

The superstorm is expected to inflict costly and lasting damage in Florida, as the Federal Reserve is already keeping an eye ...

The UK FTSE 100 index increased by 0.3%, driven by significant gains in GSK following a settlement in the U.S. The market ...